This site is intended for healthcare professionals only
LoginRegister
Sun Pharma Halol facility gets OAI status from USFDASun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag InternationalDarzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma:...
India offers Rs 10 crore reward for new drug to treat sickle cell diseaseIndia offers Rs 10 crore reward for new drug to treat sickle cell disease
Mankind Pharma bags CDSCO nod to start Phase 1 trials of Autoimmune drug candidateMankind Pharma Gets CDSCO Panel Nod to Conduct Phase III Trial of Resmetirom Tablets
Biocon Opens First US Manufacturing Facility in New Jersey, Invests USD 30 Million in ExpansionBiocon concludes Rs 4500 crore equity fundraise through QIP
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDCZydus Gets CDSCO Panel Nod to Conduct Phase IV Trial for Indacaterol-Budesonide FDC Inhalation
Granules India Hyderabad API facility gets 1 USFDA observationGranules India Bonthapally API facility gets 1 USFDA observation
Counterfeit version of Sun Pharma Cholesterol lowering drugs worth Rs 3 lakhs seized in HyderabadCounterfeit version of Sun Pharma Cholesterol lowering drugs worth Rs 3 lakhs seized in Hyderabad
USFDA Reappoints Vinay Prasad to Top Medical and Scientific RoleVinay Prasad named Chief Medical and Science Officer at USFDA: Report
Sanofi DupixentSanofi Dupixent gets USFDA nod for bullous pemphigoid treatment in adults
Natco Pharma gets 7 USFDA observations for Kothur Pharma DivisionUSFDA inspection: Natco Pharma gets 7 observations for Kothur Pharma Division
CDSCO Panel Rejects Phase II Data for Reliances RelCoVax COVID-19 Booster Over Immunogenicity GapCDSCO Panel Rejects Phase II Data for Reliance's RelCoVax COVID-19 Booster Over Immunogenicity Gap
X